Abstract:
:Gemifloxacin is a novel fluoroquinolone with a broad spectrum of activity. This double-blind, randomized, parallel-group study was designed to demonstrate the lack of effect of steady-state concentrations of gemifloxacin on the pharmacodynamic effects of warfarin. Healthy male subjects received loading doses of warfarin on days 1 and 2. The warfarin dose was freely titrated until day 10, with the aim of achieving a stable international normalized ratio (INR) for prothrombin time within the range 1.3-1.8 by day 14. On days 14-24 the dose of warfarin was fixed. On days 18-24, subjects also received 320 mg of gemifloxacin or matched placebo, once daily. Thirty-five subjects entered into and completed the co-administration phase of the study. The mean (standard deviation) baseline INR (mean of days 16-18) and INR for day 24 for gemifloxacin plus warfarin were 1.52 (0.12) and 1.46 (0.15), respectively. Corresponding values for placebo plus warfarin were 1. 46 (0.11) and 1.42 (0.17). The point estimate (90% confidence interval) for the difference in day 24 INR, adjusted for baseline, between gemifloxacin and placebo was 0.02 (-0.08, 0.12), which translates to an INR (relative to placebo least squares mean of 1.43) of 1.02 (0.95, 1.09). The 90% confidence interval for the difference in INR between the gemifloxacin and placebo groups was completely contained within the 25% equivalence range. There were no changes of clinical significance in vital signs, 12-lead electrocardiogram readings or laboratory parameters for any subject during the co-administration phase of the study, and no adverse experiences relating to coagulation were reported during this period. It is concluded that the pharmacodynamic effects of warfarin are not affected by gemifloxacin, and therefore both drugs can be co-administered without dosage adjustment.
journal_name
Chemotherapyjournal_title
Chemotherapyauthors
Davy M,Bird N,Rost KL,Fuder Hdoi
10.1159/000007243subject
Has Abstractpub_date
1999-11-01 00:00:00pages
491-5issue
6eissn
0009-3157issn
1421-9794pii
che45491journal_volume
45pub_type
临床试验,杂志文章,随机对照试验相关文献
CHEMOTHERAPY文献大全abstract::Antibacterial kinetics of modified-release clarithromycin (CLA) and azithromycin (AZI) against respiratory tract pathogens were compared in relation to their pharmacokinetic profile. The study was carried out in three strains of Streptococcus pneumoniae, group A beta-hemolytic Streptococcus pyogenes, Moraxella catarrh...
journal_title:Chemotherapy
pub_type: 杂志文章
doi:10.1159/000007308
更新日期:2000-09-01 00:00:00
abstract:BACKGROUND:To define the maximum tolerated dose (MTD) tolerability and efficacy of intra-arterial chemotherapy with irinotecan in patients with liver metastases of colorectal carcinoma (CRC). METHODS:Superselective intra-arterial irinotecan was applied on days 1, 14, 28 and 42. The initial dose was 140 mg/m² with esca...
journal_title:Chemotherapy
pub_type: 杂志文章,随机对照试验
doi:10.1159/000348579
更新日期:2013-01-01 00:00:00
abstract::Serial serum erythropoietin (EPO) levels were measured in 12 adult lung cancer patients during cancer chemotherapy. In major cases, EPO levels increased significantly after chemotherapy while the hemoglobin (Hb) remained at initial levels. EPO fell gradually or rapidly to initial levels after a peak, although the pati...
journal_title:Chemotherapy
pub_type: 杂志文章
doi:10.1159/000239014
更新日期:1992-01-01 00:00:00
abstract:BACKGROUND:Gram-negative bacilli are the most common bacteria causing nosocomial bloodstream infections (NBSIs) in Latin American countries. METHODS:The antibiotic resistance profiles of Gram-negative bacilli isolated from blood cultures in pediatric patients with NBSIs over a 3-year period in a tertiary care pediatri...
journal_title:Chemotherapy
pub_type: 杂志文章
doi:10.1159/000362085
更新日期:2013-01-01 00:00:00
abstract::We tested 42 strains of amikacin-resistant gram-negative bacilli with amikacin in combination with six beta-lactam antibiotics using the checkerboard and time-kill curve techniques. Synergism was demonstrated with time-killing curve in 43-68% of the strains tested. Ceftazidime plus amikacin was the most active combina...
journal_title:Chemotherapy
pub_type: 杂志文章
doi:10.1159/000238556
更新日期:1988-01-01 00:00:00
abstract::AM-1155 is a new 8-methoxyquinolonecarboxylic acid with a broad spectrum of antibacterial activity. It inhibited more than 90% of clinical isolates of Streptococcus agalactiae, Escherichia coli, Peptostreptococcus magnus, Bacteroides fragilis and Prevotella bivia at the concentration of 3.13 mg/l. The antibacterial ac...
journal_title:Chemotherapy
pub_type: 杂志文章
doi:10.1159/000007120
更新日期:1998-07-01 00:00:00
abstract::Our previous studies demonstrated the efficacy of cationic liposome-encapsulated doxycycline (CaL-DOX) on the course of infection with Chlamydia trachomatis in vitro and in vivo. In this investigation, the pharmacokinetics of CaL-DOX are reported. Female mice inoculated intravaginally with 4.84 x 10(5) inclusion-formi...
journal_title:Chemotherapy
pub_type: 杂志文章
doi:10.1159/000077279
更新日期:2004-04-01 00:00:00
abstract::A rational choice of an antimicrobial agent must take into account not only the activity against the specific pathogen but also any possible negative or positive effects on the host defense system. Rokitamycin (RKM) is an orally active 16-membered-ring macrolide; there are no reports of specific investigations of thes...
journal_title:Chemotherapy
pub_type: 杂志文章
doi:10.1159/000239560
更新日期:1997-05-01 00:00:00
abstract::A total of 30 hospitalized patients with upper and lower urinary tract infections were treated with cefotaxime (HR-756) by intramuscular or intravenous route. All patients had a monomicrobial infection, and the major part of bacterial isolates were gram-negative bacilli (83%) while gram-positive cocci accounted only f...
journal_title:Chemotherapy
pub_type: 杂志文章
doi:10.1159/000238061
更新日期:1982-01-01 00:00:00
abstract::Niridazole was shown to be an effective chemotherapeutic agent for mice infected intravenously with a niridazole-sensitive strain of Salmonella typhimurium. Death rates as well as bacterial counts per spleen were reduced, even in compromised animals. Histologic examination of spleens proved the reduction of inflammato...
journal_title:Chemotherapy
pub_type: 杂志文章
doi:10.1159/000238069
更新日期:1982-01-01 00:00:00
abstract::Gametocytocidal activity of artemisinin (qinghaosu) has been demonstrated against simian malaria parasite Plasmodium cynomolgi B. Colony-bred Anopheles stephensi were allowed to feed on gametocyte-carrying rhesus monkeys and the mosquito infectivity rate and oocyst count of the infected mosquito gut were recorded on d...
journal_title:Chemotherapy
pub_type: 杂志文章
doi:10.1159/000238671
更新日期:1989-01-01 00:00:00
abstract:BACKGROUND:Ginkgolic acids (GAs), extracted from the seed coat of Ginkgo biloba L. Our previous study has shown that GA monomer could inhibit the growth of Hep-2 significantly and induce the fragmentation of the chromosomal DNA. To further assess the antitumor potential and turn it into a candidate new antitumor drug, ...
journal_title:Chemotherapy
pub_type: 杂志文章
doi:10.1159/000317750
更新日期:2010-01-01 00:00:00
abstract::Thirteen quinolone antibacterial agents were investigated as to their ability to inhibit Micrococcus luteus DNA gyrase and cell growth, and compared to those of novobiocin and coumermycin. Among the quinolones tested, the most active were found to be CI-934 and ciprofloxacin, which inhibited gyrase full supercoiling a...
journal_title:Chemotherapy
pub_type: 杂志文章
doi:10.1159/000238458
更新日期:1986-01-01 00:00:00
abstract:BACKGROUND:Ceftazidime is a third-generation cephalosporin almost entirely eliminated by glomerular filtration and dose reductions are essential in patients with renal impairment. The physicochemical and pharmacokinetic properties of ceftazidime make it susceptible to be eliminated by continuous renal replacement thera...
journal_title:Chemotherapy
pub_type: 临床试验,杂志文章
doi:10.1159/000100864
更新日期:2007-01-01 00:00:00
abstract::137 patients with febrile neutropenia after cytotoxic therapy not responding to ceftazidime plus or ceftriaxone plus netilmicin in received additionally to the previous combination either vancomycin alone or combined with another anti-gram-negative compound: imipenem in those treated prophylactically with ofloxacin an...
journal_title:Chemotherapy
pub_type: 杂志文章
doi:10.1159/000239434
更新日期:1996-03-01 00:00:00
abstract::The post-antibiotic effects (PAEs) of a new cephalosporin, cefdinir, were determined against a range of organisms using a viable counting technique. Cefdinir exerted considerable PAEs against Staphylococcus aureus and Streptococcus pyogenes, but no overall post-antibiotic inhibition of growth was detected against Esch...
journal_title:Chemotherapy
pub_type: 杂志文章
doi:10.1159/000239198
更新日期:1994-07-01 00:00:00
abstract::Rifampicin and rifapentine were used in the treatment of Listeria monocytogenes infections in normal mice and congenitally athymic (nude) mice. Results were compared with untreated controls and with the results obtained from a previous study of ampicillin in which this model was used. Low doses of rifampicin or rifape...
journal_title:Chemotherapy
pub_type: 杂志文章
doi:10.1159/000238268
更新日期:1984-01-01 00:00:00
abstract::Ten years of controlled clinical trials supported single-dose therapy efficacy and safety in uncomplicated lower urinary tract infections (UTI). Both local and systematic factors contribute to the high UTI prevalence seen in elderly people. A controlled open randomized study was undertaken to evaluate the clinical eff...
journal_title:Chemotherapy
pub_type: 临床试验,杂志文章,随机对照试验
doi:10.1159/000238817
更新日期:1990-01-01 00:00:00
abstract::Some acridine compounds referred to as 9-imino, 9-oxo and 9-thio derivatives were screened for activity against Trypanosoma cruzi in vitro. The results are discussed here with reference to the structure of the compounds tested. Attempts to elucidate the mode of action of active acridines are also included. The most ac...
journal_title:Chemotherapy
pub_type: 杂志文章
doi:10.1159/000238559
更新日期:1988-01-01 00:00:00
abstract::The in vitro bactericidal effects of therapeutic concentrations of levofloxacin (LVFX) on clinical isolates of Pseudomonas aeruginosa and Enterococcus faecalis were assessed. Starting from 10(7) CFU/ml, the bacterial count was determined serially during the exposure to LVFX present at concentrations automatically simu...
journal_title:Chemotherapy
pub_type: 杂志文章
doi:10.1159/000007133
更新日期:1998-09-01 00:00:00
abstract:BACKGROUND:Cisplatin (CDDP) is known to cause inner ear damage while carboplatin (CBDCA) induces less ototoxicity than CDDP. We examined apoptotic changes in the cochlea of guinea pigs after injection of CDDP or CBDCA using immunohistochemical and electrophysiological techniques. METHODS:Three days after the injection...
journal_title:Chemotherapy
pub_type: 杂志文章
doi:10.1159/000057667
更新日期:2002-05-01 00:00:00
abstract::This study was performed in female B6C3F1 mice to confirm previously observed effects of selected cephalosporin antibiotics on nonspecific immunity, and to determine possible effects on specific acquired immunity and host resistance. Mice were treated intravenously with DQ-2556, ceftizoxime or ceftezole at 800 mg/kg/d...
journal_title:Chemotherapy
pub_type: 杂志文章
doi:10.1159/000239137
更新日期:1993-07-01 00:00:00
abstract::A new semisynthetic ureidopenicillin (Bay K 4999) demonstrates favorably in vitro antibacterial efficacy against human-pathogenic gram-negative rods in comparison to mezlocillin and azlocillin. A comparative paramcokinetic study was done with 10 test subjects after 30 min intravenous infusion of 4.0 g of Bay K and mez...
journal_title:Chemotherapy
pub_type: 杂志文章
doi:10.1159/000237887
更新日期:1980-01-01 00:00:00
abstract::The in vitro activity of cefetamet against Escherichia coli, Klebsiella pneumoniae and Serratia marcescens strains expressing an SHV-5-type beta-lactamase was evaluated. Most of the examined strains were susceptible to the antibiotic. Cefetamet was found to be considerably more active than ceftazidime and aztreonam. I...
journal_title:Chemotherapy
pub_type: 杂志文章
doi:10.1159/000239462
更新日期:1996-09-01 00:00:00
abstract::The antimicrobial resistance patterns of respiratory pathogens isolated during an 8-year period (1990-1997) in an Italian hospital from patients with bronchopulmonary infections were investigated. A global variation in the resistance of Staphylococcus aureus to all relevant antibiotics was observed during the years 19...
journal_title:Chemotherapy
pub_type: 杂志文章
doi:10.1159/000007273
更新日期:2000-05-01 00:00:00
abstract:BACKGROUND:Nevirapine (NVP) is a nonnucleoside reverse transcriptase inhibitor used in HIV patients and recently evaluated as a differentiating and antiproliferative agent in human malignancies. However, while NVP is a safe treatment in immunocompromised patients, NVP-containing regimens have been associated with sever...
journal_title:Chemotherapy
pub_type: 临床试验,杂志文章
doi:10.1159/000159273
更新日期:2008-01-01 00:00:00
abstract:BACKGROUND:An ethylacetate-soluble fraction (ET4) from the lichen Ramalina farinacea has previously been shown to inhibit the infectivity of lentiviral and adenoviral vectors, as well as wild-type HIV-1. We now determined the antiviral activity of ET4 against other wild-type viruses, including the herpes simplex virus ...
journal_title:Chemotherapy
pub_type: 杂志文章
doi:10.1159/000194974
更新日期:2009-01-01 00:00:00
abstract::We have treated 45 cases of urinary tract infection with cefazolin (i.m.) and cure was achieved in 35 (77.77%). 26 of the 28 patients (92.85%) with acute cystitis who received 250 mg every 12 h for 6-10 days were cured. 17 patients with pyelonephritis received 500 mg every 12 h during 10-14 days and therapeutical succ...
journal_title:Chemotherapy
pub_type: 杂志文章
doi:10.1159/000221978
更新日期:1977-01-01 00:00:00
abstract::We evaluated the efficacy of S-1 as a new oral antitumor agent in ovarian cancer-bearing nude rats. This drug consists of tegafur, 5-chloro-2,4-dihydroxypyridine, and oxonic acid in a molar ratio of 1:0.4:1.S-1 was given alone or in combination with cisplatin. When administered alone at a daily dose of 20 mg/ kg, S-1 ...
journal_title:Chemotherapy
pub_type: 杂志文章
doi:10.1159/000239479
更新日期:1996-11-01 00:00:00
abstract:BACKGROUND:Ciprofloxacin is commonly used and considered to be relatively safe in patients with cirrhosis, especially in the treatment of enteric and urinary tract infections. Among the adverse effects of ciprofloxacin, neurologic complications are rare. METHODS/RESULTS:We report a case of hemiballism and altered ment...
journal_title:Chemotherapy
pub_type: 杂志文章
doi:10.1159/000218098
更新日期:2009-01-01 00:00:00